Innova Captab Limited (NSE:INNOVACAP)

Market Cap	52.27B
Revenue (ttm)	11.92B
Net Income (ttm)	1.27B
Shares Out	57.22M
EPS (ttm)	25.20
PE Ratio	36.25
Forward PE	30.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	78,436
Average Volume	58,001
Open	910.10
Previous Close	913.45
Day's Range	903.55 - 927.00
52-Week Range	421.35 - 1,260.00
Beta	n/a
RSI	57.63
Earnings Date	May 29, 2025

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antieme...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 1,600
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INNOVACAP

Financial Performance

In 2023, Innova Captab's revenue was 10.81 billion, an increase of 16.72% compared to the previous year's 9.26 billion. Earnings were 943.45 million, an increase of 38.84%.